Hybio Pharmaceutical Co., Ltd. (SHE:300199)
22.67
-0.81 (-3.45%)
Aug 26, 2026, 3:04 PM CST
Hybio Pharmaceutical Employees
Hybio Pharmaceutical had 1,226 employees as of December 31, 2025. The number of employees increased by 191 or 18.45% compared to the previous year.
Employees
1,226
Change (1Y)
191
Growth (1Y)
18.45%
Revenue / Employee
901.47K CNY
Profits / Employee
104.24K CNY
Market Cap
20.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,226 | 191 | 18.45% |
| Dec 31, 2024 | 1,035 | 140 | 15.64% |
| Dec 31, 2023 | 895 | -80 | -8.21% |
| Jan 1, 2023 | 975 | 90 | 10.17% |
| Jan 1, 2022 | 885 | -56 | -5.95% |
| Dec 31, 2020 | 941 | -118 | -11.14% |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tasly Pharmaceutical Group | 10,563 |
| Harbin Pharmaceutical Group | 10,039 |
| Livzon Pharmaceutical Group | 8,878 |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6,003 |
| Kangmei Pharmaceutical | 5,492 |
| Jilin Aodong Pharmaceutical Group | 5,461 |
| Chengdu Kanghong Pharmaceutical Group | 4,470 |
| Shanghai Haoyuan Chemexpress | 4,195 |
Hybio Pharmaceutical News
- 2 months ago - US Food and Drug Administration to review Hybio's generic GLP-1s - Reuters